Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Jun 03, 2024 3:48pm
216 Views
Post# 36069914

RE:RE:RE:Only In Canada you say !

RE:RE:RE:Only In Canada you say !Hi skys1 - That's very interesting. In the current MD&A it says that an animal trial is ongoing:

"...These results have now laid the groundwork for the next phase of the CRA, which is evaluating the Theralase® COVID-19 vaccine in the ability to prevent animals from contracting COVID-19, when exposed to the virus, which commenced in 4Q2023 and is expected to be completed by 4Q2024."

Hopefully we'll hear about next steps at the end of 2024.

skys1 wrote: "fantastic developement", I agree Eoganacht. They found, the "capacity of the compound to inactivate every tested virus". A couple years ago, I spoke with Dr. Coombs just after he forwarded all his level 1 bio lab's records and findings to DR. Kobassa and his bio 2 lab for further work, both in Winnigeg.
Dr. Coombs said, "I have never seen anything like it. 1433 killed every virus we tested it on". He was very enthusiastic. It appears both studies arived at the same conclusion. Both stidies produced a "fantastic developement", what else could they want?  Then the Company and the gov of Canada embarked a joint program to work on these remarkable results. I've really expected something more on this for some time.
This could be worth immeasurable value.Remember the hundreds of $billions the covid vaccines produced? No telling what it could be worth to TLT. I don't understand why nothing has come of this yet.
Maybe we are finally there.


<< Previous
Bullboard Posts
Next >>